INTRODUCTION
T he modified Rankin Scale (mRS) originally was developed in the 1950s for the assessment of functional outcome in patients recovering from neurological deficits caused by a spontaneous stroke. 1 In the late 1980s, the mRS was modified to its current form of a 7-tier classification, in which 0 represents an asymptomatic and 6 a deceased patient. 2 In clinical practice, the mRS is a simple and widely applicable scale, and its interrater variability is low. [3] [4] [5] Neurosurgical society has adopted the mRS to assess outcomes after various neurosurgical treatments. Postoperative mRS scores are suggested to represent surgical outcome in cranial tumor surgery, [6] [7] [8] and perhaps even more so in cerebrovascular surgery. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] As an example of a widespread use of mRS in neurosurgery, most influential studies on cerebrovascular surgery, such as the first randomized treatment trial of unruptured brain arteriovenous malformations (A Randomized Trial of Unruptured Brain Arteriovenous Malformation [ARUBA]), 25 the International Study of Unruptured Intracranial Aneurysms (ISUIA), 26 and the International Subarachnoid Aneurysm Trial (ISAT) [22] [23] [24] have each reported outcomes and compared treatment results by the mRS. In the ARUBA and the ISUIA studies the mRS was assessed at postoperative followup visits or telephone contacts whereas in the ISAT study the mRS was assessed using a mailed questionnaire adapted from Lindley and colleagues. 27 A number of other outcome scores also are available in neurosurgery. For example, the Glasgow Outcome Scale is used for patients with brain injury/trauma 28 and the Karnofsky Performance Score 29 or Eastern Cooperative Oncology Group Performance Status score 30 for patients with brain tumors. These scores are only applicable for specific patient subgroups, however, unlike the mRS with its wide use in cranial neurosurgery.
In this prospective and unselected cohort study, we attempted to define the role of the mRS, recorded with methods similar to the ISUIA and ARUBA, in detecting various short-term outcomes in elective cranial neurosurgery. Specifically, our aim was to determine which complications cause changes in postoperative mRS scores and whether postoperative changes in mRS scores represent the overall short-term surgical outcome of elective craniotomy patients.
MATERIALS AND METHODS

Ethical Statement
The Ethics Committee of the Hospital District of Helsinki and Uusimaa reviewed and approved the study. All subjects gave their written informed consent before enrollment.
Study Population and Data Collection
The cohort comprised consecutive and unselected adult patients (!18 years) who underwent elective intracranial surgeries in Helsinki University Hospital between December 7, 2011, and December 31, 2012. The enrollment protocol has been described in a previous article. 31 Data collection included patient-reported health-related data collected through 2 questionnaires (1 preoperatively and 1 at hospital discharge), tailored for the purposes of this study. To minimize surgeon-related interpretation bias, a study anesthesiologist recorded the mRS score for each patient. In addition, the study anesthesiologist systematically recorded additional data on inhospital complications and unplanned reoperations within 30 postoperative days. If the patient was still hospitalized on day 30, hospital discharge data also were recorded on day 30. For patients who were discharged and readmitted for an unplanned reoperation within the 30-day follow-up, the hospital discharge data were recorded at initial discharge. Hospital databases and the Population Register Center were checked for confirming mortality figures (inhospital and 30-days). A more detailed description of data collection is available in an online supplement.
Postoperative Complications
Postoperative in-hospital major complications comprised mortality, new or worsened hemiparesis, silent stroke (radiological finding without clinical symptoms), deep-vein thrombosis, pulmonary embolism, acute myocardial infarction, and pneumonia. The hemipareses were recorded at discharge, but other major complications at any time during the hospital stay. Unplanned recraniotomies or endovascular interventions within 30 postoperative days also were considered major complications.
Recorded minor complications included subjective visual disturbances, minor infections, new or worsened facial nerve palsies, wound infections, meningitis (no neurological deterioration), subjective dysphagia, dysphasia/dysarthria, and unplanned cranial minor reoperations such as ventriculostomy and wound revision in the operating room (OR). These reoperations did not include tracheostomy, extracranial reoperations, or reoperations performed outside the OR (bedside). In-hospital complications data were retrieved from three sources: patient questionnaires, study forms filled by study anesthesiologists at hospital discharge, and hospital patient records.
mRS Assessments
The mRS score was recorded on admission, at discharge, and at 30 days after surgery. A face-to-face assessment occurred on admission and at discharge, whereas a structured telephone interview was used at 30 days. 3 The difference between the preoperative and postoperative mRS scores received the designation "mRS-score difference."
Statistical Analyses
For association analyses between mRS score and specific complications, we assigned each patient to one complication phenotype. Patients identified as having only one complication underwent separate association analyses. Ranking the significance of complications was done using Pearson chi-square test-based univariable analyses of all complications with mRS-score difference >2 between hospital discharge and preoperative mRS-scores. Significant (P values <0.05) complications in the univariable analyses were entered into logistic regression multivariable analysis, and the most significant complications were ranked in order. All statistically nonsignificant major and minor complications were ranked in order by frequency. This ranking order of complication phenotypes enabled assigning one patient to only one complication phenotype, when this was needed in further statistical analyses. Two-way (2 Â 2) contingency tables provided means for sensitivity, specificity, and positive predictive value and negative predictive value calculations. The corresponding author (E.R.) conducted the statistical analyses with the IBM SPSS Statistics for Windows and Mac OX, Version 21.0 (IBM, Corp., Armonk, New York, USA).
RESULTS
Study Cohort and Craniotomies
Of the 418 study patients, 260 (62%) were female. Mean and median ages were 56.4 and 58.0 years (range 18À87). Surgical indications included vascular lesions (intracranial aneurysm or arteriovenous malformation) for 138 (33%), benign tumors for 134 (32%), and malignant tumors for 121 (29%) patients. One-quarter (25%) of the craniotomies were infratentorial. Table 1 shows the recorded individual complications and the frequency of their combinations. The rates of individual complications have been described previously. 32 Of 418 patients, 194 (46%) had 1 or more in-hospital complications. Of the 194 patients, only 1 complication occurred in 120 (62%), whereas the remaining 38% (73 patients) had multiple complications. Four patients (1%) died (mRS ¼ 6) in the hospital. The 30-day mortality rate was 2% (10 patients). One patient who died in the hospital had no recorded major or minor complications, but massive pulmonary embolism emerged in the autopsy.
In-Hospital Complications and 30-Day Mortality
Major Complications. In-hospital deaths excluded, the rate of major complications was 18%. The number of sole major complications was limited (35 of 76 patients). The three most frequent inhospital major complications were new or worsened hemiparesis (10%), unplanned recraniotomy or endovascular intervention (4%), and pneumonia (3%). Numbers and percentages of patients with decreased/no change or increase in modified Rankin Scale (mRS) score differences at hospital discharge and at 30 days and the rate of complications in subgroups with minor or no preoperative functional disability (mRS score 0e1) and preoperative functional dependence (mRS score >2). incl., including; excl., excluding.
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At 30-day follow-up, 340 patients (81%) answered the telephone interview. Including the 10 patients who died within 30 days after surgery, a total of 350 patients were included in the 30-day analyses. At 30 days, 267 (76%) of these patients were functionally independent (mRS score <3), and the median mRS score was 1.
mRS Score Differences and Complications
For the differences between preoperative and postoperative mRS scores, data were available for 405 patients at discharge and 349 at the 30-day follow-up. Figure 2 summarizes mRS-score differences between preoperative and postoperative mRS scores in patients with no or minor (mRS ¼ 0À1) preoperative functional disability, as well as in preoperatively dependent (mRS score >2) patients. Overall, 138 (34%) and 54 (13%) patients had mRS-score differences >0 and >1 at discharge, respectively. Of 216 patients with no recorded in-hospital complications, mRS scores at discharge increased in 37 (17%). Especially patients with preoperative mRS scores 0 or 1 appeared to have deteriorating mRS scores at discharge without any objective complications (Figure 2) . Additionally, 41 (55%) of 75 patients with major in-hospital complications (including mortality) did not have an mRS-score difference >1 at discharge (Supplementary Table 2) .
At 30 days, 126 (36%) and 57 (16%) of the 349 patients had respective mRS score differences of >0 and >1. Interestingly, mRS scores worsened from discharge to 30 days in 45 (24%) of the 189 patients with no in-hospital complications. From discharge to 30 days, mRS scores improved in 101 (29%) of 349 patients and remained unchanged in 122 (35%). Anecdotally, 39 (42%) of 92 patients without preoperative functional impairments (mRS score ¼ 0À1) and without in-hospital complications reported increased mRS scores at 30 days.
Two-thirds (66%) of the patients with the greatest ranked complication phenotype (new hemiparesis) had other major or minor complications as well. An mRS score worsening at 30 days was associated with the composite complication outcome measures, that is, the major (P < 0.001) and minor (P ¼ 0.030) complications; however, the sensitivity, specificity, positive predictive value, and negative predictive value of the mRS-score differences, even for major and minor complications, were poor (Supplementary Table 3 ).
DISCUSSION
Nearly one-fifth of patients without any complications had increased mRS scores at discharge, and approximately three-fifths with minor complications had no mRS-score increase at all. At 30 postoperative days, the correlation further weakened, as one-fourth of the patients without complications had an mRS score difference >0. As only 35% of these patients underwent surgery for malignant intracranial tumors, neither early progression of the disease nor postoperative tumor treatment explain this observed trend.
In outcome and treatment comparisons, mRS-based outcome often is dichotomized into good (mRS 2) and poor (mRS >2). One-fifth (20%) of the cerebrovascular and one-fourth (25%) of all tumor patients had mRS scores >2 at discharge in our study. Of all these patients, roughly one-third (35%) already had an mRS score >2 preoperatively. Most surprisingly, only 57% of all patients with mRS score >2 at discharge had major complications.
The underlying reasons for the unpredictability of perioperative changes in the mRS scores with regard to recorded complications are probably complex. The possible effect of postoperative pain or fatigue may have led to perioperative loss of function (mRS-score difference >0) even in the absence of major complications, especially in the subgroup of patients who had none or mild symptoms preoperatively (mRS score 0e1). We have found previously that dependent functional status (mRS score !3) at 30 days associates with both patient-reported postoperative deterioration in subjective functional status as well as with patient-reported poor overall health. 33 Moreover, patients with preoperative mRS scores 0 and 1 may experience undefined functional impairments even without an objective evidence of postoperative complications as suggested by the presented results. In contrast, patients with high preoperative mRS scores may experience no changes in their well-being and functionality even after serious complications. In brief, postoperative functional changes in mRS are often unassociated with objectively recorded complications. Because psychosocial and cognitive factors may play a role in subjective postoperative functional status, the use of mRS as a surgical outcome measure is perhaps questionable.
Strengths and Limitations of the Study
The strengths of this unselected cohort study include its prospective design with tailored postoperative adverse event recording. Moreover, mRS scores were assessed by anesthesiologists who are unlikely to have any bias in reporting surgical outcome. Furthermore, mRS assessment protocol was similar to the ARUBA and ISUIA. In the ARUBA study, mRS scores were recorded at baseline and at each follow-up visit or telephone contact. In the ISUIA study, the mRS was recorded at each follow-up visit which were scheduled at 7 days, at discharge, at 30 days, and then at yearly intervals. The study has a number of limitations. First, a selection bias cannot be excluded, because only 76% of all eligible patients participated in the study. Second, the interrater variability of the mRS is relatively low [3] [4] [5] but cannot be excluded. Third, the response rate for the 30-day telephone interview was only 81%. We performed a posthoc analysis of the dropout effect relying on the outpatient hospital records, but the results remained unchanged (results not shown). Fourth, silent strokes were included in major complications, even though they are not expected to affect the functional status. When the analyses were repeated excluding the silent strokes, however, the results remained unchanged (results not shown). Fifth, our follow-up can be considered short. However, if mRS score does not change during short-term follow-up, or changes even without any observed complications, it is unlikely that a long-term follow-up would provide more reliable results. Sixth, the methods of measuring postoperative mRS differed at discharge (anesthesiologist's objective assessment) and at 30 days (patient's subjective reporting in a structured telephone interview), and subjectivity in the 30-day mRS scores cannot be excluded.
CONCLUSIONS
The mRS reflects the rate of postoperative hemiparesis to some extent, but hemiparesis only accounts for a small fraction of complications in cranial neurosurgery. The mRS score differences associate poorly with the described complications in modern elective cranial neurosurgery, even if it measures subjective functional changes. The neurosurgical community could benefit from a consensus on more objective outcome measurements. 
Anesthesiologist-Filled Study Form and Hospital Patient Records
At the time of the preoperative consultation, a study anesthesiologist filled a study form on each patient. Information was retrieved from hospital databases as necessary. If blood pressure and heart rate were not measured at preoperative consultation, we used the first measurements in the OR before the beginning of the anesthesia. The recorded data comprised: Additionally, the patients filled a postoperative TYM test form, identical to the preoperative test.
Hospital Patient Records
Hospital patient records provided data on in-hospital complications. A study anesthesiologist manually extracted the following data for all study patients: A study anesthesiologist manually extracted data on reoperations involving the brain for the time period between hospital discharge and the end of 30-day follow-up.
The Population Register Center database provided mortality data for all study patients at 30-day follow-up.
MISSING DATA
Complete data were unavailable for some patients. Patient questionnaires and study forms were incompletely filled or not returned in 119 cases (28.5%). Objective variables, such as inhospital complications were manually extracted from patient records as necessary. Thus, complete in-hospital complications data was available for all study patients. A total of 68 patients (16.3%) were lost to follow-up at 30 days. We obtained the 30-day mRS scores for 62 patients lost to follow-up for post hoc analyses. 0  1  0  1  0  1  1  0  1  0  0  1  1  0  0  1   D V T  0  2  0  2  1  1  0  2  1  1  2  0  0  2  2  0   SVD  11  29  5  32  12  28  15  22  17  23  17  20  4  36  9  28   Speech  6  10  7  7  5  11  3  11  5  11  4  10  0 Low patient counts (<5 patients) made sensitivity, specificity, and positive-, and negative predictive values not applicable for AMI, PE, DVT, N. facialis, WI/meningitis, and unplanned cranial minor reoperation complication phenotypes or sole complications, nor for pneumonia phenotype or silent stroke sole complication. sens., sensitivity; spec., specificity; PPV, positive predictive value; NPV, negative predictive value, mRS, modified Rankin Scale; Hemi, new or worsened hemiparesis; Re-CRT; re-craniotomy; EI, endovascular intervention; SVD, subjective visual disturbance; AMI, acute myocardial infarction; PE, pulmonary embolism; DVT, deep-vein thrombosis; N., nervus; WI, wound infection; incl., including; excl., excluding.
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